| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2016 | McGrath John | Chief Financial Officer | Sell | 5,000 | $17.47 | $87,325.00 | -2.5% | |
| Sep 28, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 12,000 | $20.87 | $250,446.00 | -1.0% | |
| Sep 16, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,200 | $19.36 | $139,356.00 | -0.8% | |
| Aug 23, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 9,600 | $22.33 | $214,368.00 | -1.1% | |
| Aug 16, 2016 | Soffer Gad | Chief Operating Officer | Sale+OE | 5,356 | $22.41 | $120,039.64 | -1.8% | |
| Aug 15, 2016 | Haqq Christopher | Chief Medical Officer | Sale+OE | 1,346 | $22.32 | $30,040.68 | -0.2% | |
| Jul 21, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 9,600 | $22.11 | $212,208.00 | -1.5% | |
| Jul 8, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 9,600 | $22.88 | $219,648.00 | -1.4% | |
| Jun 24, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 9,600 | $21.26 | $204,048.00 | -1.4% | |
| Jun 8, 2016 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 12,000 | $20.53 | $246,372.00 | -1.1% |